Despite a clear correlation between the infiltration of periodontal pathogens in the brain and
cognitive decline in
Alzheimer's disease (AD), the precise mechanism underlying bacteria crossing the blood-brain barrier (BBB) remains unclear. The periodontal pathogen Porphyromonas gingivalis produces a unique class of
cysteine proteases termed
gingipains.
Gingipains appear to be key
virulence factors that exacerbate sporadic AD. We herein report that
gingipains are involved in increasing permeability of hCMEC/D3 cell monolayer, human cerebral microvascular endothelial cell lines, through degradation of
tight junction proteins including Zonula occludens-1 (ZO-1) and
occludin. There was a significant decrease in the mean
protein levels of ZO-1 and
occludin after
infection of hCMEC/D3 cells with wild-type (WT) P. gingivalis. However,
infection of these cells with a
gingipain-deficient P. gingivalis strain showed significantly lower reduction of the mean
protein levels of either ZO-1 and
occludin, compared to the WT strain. Similar results were obtained
after treatment with culture supernatant from WT and
gingipain-deficient P. gingivalis strains. In vitro digestion of human recombinant ZO-1 and
occludin by WT P. gingivalis culture supernatant in the absence or presence of
gingipain inhibitors indicated that
gingipains directly degraded these
tight junction proteins. A close immunohistochemical examination using anti-
gingipain antibody further revealed that
gingipains localized in the cytosol and nuclei of hCMEC/D3 cells after
infection with WT P. gingivalis and treatment with its culture supernatant. Furthermore, intracellular localization of outer membrane vesicles (OMVs) bound
gingipains from WT P. gingivalis and OMV-induced degradation of ZO-1 and
occludin were also observed in hCMEC/D3 cells. Thus, the delivery of
gingipains into the cerebral microvascular endothelial cells, probably through OMV, may be responsible for the BBB damage through intracellular degradation of ZO-1 and
occludin.